Haemodynamic effects of diuretics in heart failure E B Raftery
The organic mercurials have been known to have a diuretic effect since the sixteenth century, but their use for treating dropsy first began in 1920 in Vienna, when it was realised that a mercury compound being used to treat syphilis greatly increased urine output. The direct descendant of that compound was mersalyl, which was to remain the drug of choice until 1951, when the carbonic anhydrase inhibitors were introduced.
One reason for the slow development of interest in the diuretics was the reluctance of the medical profession to accept that they were as good or even better than digitalis for the management of congestive heart failure (CHF). As late as 1959 it was still necessary for clinical trials to prove what is now generally accepted: that diuretics are more effective than digitalis glycosides and are the drugs of choice for this syndrome. ' Experience has led to general acceptance that diuretics are very effective in relieving the dyspnoea and the oedema that are the hallmarks of heart failure, but it is still not clear how they achieve these results. Superficially, it seems obvious that if fluid retention results from heart failure, then anything that promotes fluid loss is bound to be beneficial. A diuretic is defined as any substance that promotes increased urine flow. In practice, however, the definition is usually confined to substances that promote the loss of sodium chloride and other small ions together with water from the extracellular fluid of the kidneys (solute diuretics). Hence the suggestion that diuretics should correct the fluid retention of heart failure, but although no one can deny that diuretics mobilise oedema and improve the quality of life, there is evidence to suggest that they may intensify the pathophysiological events that caused the oedema. The advent of peripheral vasodilators and the ACE inhibitors for the treatment of heart failure has added impetus to the examination of diuretics and their long-term effects in heart failure.
The haemodynamic effects of the diuretics In summary, the weight of evidence suggests that the primary effect of the loop diuretics in acute pulmonary oedema is a reduction of preload produced by venodilatation. However, activation of the reninangiotensin system undoubtedly increases afterload, and this effect is compounded by a significant fall in cardiac index. These effects do not seem to be related to the diuretic effects of the drug, although the findings of Nishimura and Kanbe raise some questions on this issue.22 If venodilatation is the prime mechanism for relief of pulmonary oedema, why not use an agent that produces this effect without activation of the renin-angiotensin system? Chronic congestive heart failure The published studies of the effects of diuretics in chronic CHF are on a variety of agents, protocols, therapeutic regimes, and aetiologies (table 4). The best that can be said is that all measured haemodynamic indices were depressed or unchanged by acute intravenous or oral diuretics in patients undergoing chronic treatment with digoxin and diuretics.23-3" It is not really justified to attempt a generalisation from such a disparate group, but most studies indicate less venodilatation and peripheral vasoconstriction than in patients with acute left ventricular failure. Anand and his coworkers performed a study on six untreated patients in whom frusemide was the sole medication." They documented modest falls in right sided pressures and cardiac output with a rise in peripheral vascular resistance. Verma and co-workers obtained similar results with bumetanide27 but perhaps the clearest results were those of Ikram and colleagues who gave larger doses of frusemide to 11 patients on a salt controlled diet and digoxin only.'2 They found a rapid fall in right heart pressures without a significant change in cardiac output, urine output, concentrations of aldosterone, or renin activity at five minutes, which was maintained over four hours. With Rader and colleagues published a detailed study of the organic mercurial compound mersalyl given to 14 patients with congestive heart failure to the resolution of physical signs. 23 The findings were a fall in right sided pressures with an increase in cardiac index and a fall in peripheral vascular resistance. Interestingly, all of these effects were considerably improved by the addition of oral digoxin. This suggests that mersalyl may not induce further activation of the reninangiotensin system, and might merit further investigation. The only studies involving thiazides produced results similar to those found with the loop diuretics.2426
In summary, the diuretics used to treat chronic congestive heart failure seem to produce further activation of the reninangiotensin system, with a concomitant increase in arteriolar resistance. The organic mercurials seem to be the only exception. Whether this effect is good or bad remains controversial.
Diuretics or vasodilators?
If the effects of the diuretics in producing further activation of the already activated reninangiotensin system might be disadvantageous to the patient with CHF-and there is no firm evidence that this is the case-then it seems logical to consider vasodilator drugs as a possible alternative. Drugs that produce venodilatation could reproduce the immediate haemodynamic effects of the diuretics, and if they also produce arteriolar dilatation, they might reduce afterload on the failing left ventricle and raise the cardiac output. group.bmj.com on June 25, 2017 -Published by http://heart.bmj.com/ Downloaded from eral vascular resistance and the nitrate also reduced pulmonary artery pressure. Cardiac output was increased by hydralazine but not nitrate. The addition of frusemide to nitrates reduced pulmonary capillary wedge pressure by 1 mm Hg, whereas the addition to hydralazine reduced pulmonary capillary wedge pressure by 5 mm Hg, but peripheral vascular resistance was increased. They concluded, with some reservations, that venodilatation with nitrates was preferable to arteriolar dilatation. Franciosa et al arrived at similar conclusions for nitroprusside and frusemide .35 It seems that the combination of nitrates and hydralazine has yet to be studied; the results would be of great interest, particularly in chronic CHF.
Conclusion
There can be no doubting the efficacy of the diuretics in mobilisation of oedemic fluid and the relief of dyspnoea. There is, however, a well founded suspicion that these results are related more to their haemodynamic effects than their diuretic effects, and the increased activation of the renin-angiotensin system they produce must be regarded with suspicion. It would seem that the haemodynamic effects are much the same whether the oral or intravenous route is used, but it is not clear that all diuretics induce the same haemodynamic and neurohumoral effects. It is thought that the only reliable measure of drug efficacy in heart failure is increased longevity,36 but there are no studies of the effects of diuretics on prognosis or indeed on quality of life. Until these studies are done, it would seem rash to replace the diuretics with other, more physiological drugs.
